{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:35:24Z","timestamp":1790674524855,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01730","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T23:33:52Z","timestamp":1512689632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice"],"prefix":"10.3389","volume":"8","author":[{"given":"Yu-Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Na","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ju","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Min","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3390\/v6062465","article-title":"In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen","volume":"6","author":"Wohlbold","year":"2014","journal-title":"Viruses"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","article-title":"New world bats harbor diverse influenza A viruses","volume":"9","author":"Tong","year":"2013","journal-title":"PLoS Pathog"},{"key":"B3","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1128\/JVI.65.10.5491-5498.1991","article-title":"Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins","volume":"65","author":"Ito","year":"1991","journal-title":"J Virol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.micinf.2004.10.006","article-title":"Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design","volume":"7","author":"Liu","year":"2005","journal-title":"Microbes Infect"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1073\/pnas.86.3.1061","article-title":"Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein","volume":"86","author":"Zebedee","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6597","DOI":"10.1016\/j.vaccine.2006.05.082","article-title":"Improved design and intranasal delivery of an M2e-based human influenza A vaccine","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jps.20493","article-title":"Pharmaceutical and immunological evaluation of human papillomavirus virus like particle as an antigen carrier","volume":"95","author":"Ionescu","year":"2006","journal-title":"J Pharm Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/eji.200636959","article-title":"Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design","volume":"38","author":"Bessa","year":"2008","journal-title":"Eur J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.virol.2006.12.005","article-title":"Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge","volume":"362","author":"Tompkins","year":"2007","journal-title":"Virology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.vaccine.2008.12.034","article-title":"Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys","volume":"27","author":"Fu","year":"2009","journal-title":"Vaccine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1016\/j.vaccine.2006.04.008","article-title":"Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines","volume":"24","author":"Ernst","year":"2006","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.vaccine.2007.12.027","article-title":"CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine","volume":"26","author":"Eliasson","year":"2008","journal-title":"Vaccine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1016\/j.vaccine.2009.04.075","article-title":"The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine","volume":"27","author":"Wu","year":"2009","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.vaccine.2004.05.028","article-title":"High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity","volume":"23","author":"Liu","year":"2004","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e46395","DOI":"10.1371\/journal.pone.0046395","article-title":"Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein","volume":"7","author":"Andersson","year":"2012","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.vaccine.2005.08.061","article-title":"The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/mt.2012.246","article-title":"Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus","volume":"21","author":"Kim","year":"2013","journal-title":"Mol Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e4857","DOI":"10.1371\/journal.pone.0004857","article-title":"Host genetic background strongly influences the response to influenza a virus infections","volume":"4","author":"Srivastava","year":"2009","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1016\/j.vaccine.2010.06.069","article-title":"Genetic control of immune responses to influenza A matrix 2 protein (M2)","volume":"28","author":"Misplon","year":"2010","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1016\/j.vaccine.2014.06.040","article-title":"AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection","volume":"32","author":"Lee","year":"2014","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"crossref","first-page":"8851","DOI":"10.1128\/JVI.73.10.8851-8856.1999","article-title":"Genetic reassortment of avian, swine, and human influenza A viruses in American pigs","volume":"73","author":"Zhou","year":"1999","journal-title":"J Virol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2017.08.003","article-title":"From original antigenic sin to the universal influenza virus vaccine","author":"Henry","year":"2017","journal-title":"Trends Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.4049\/jimmunol.1501637","article-title":"A novel vaccination strategy mediating the induction of lung-resident memory CD8 T cells confers heterosubtypic immunity against future pandemic influenza virus","volume":"196","author":"Lee","year":"2016","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1021\/pr200086v","article-title":"Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity","volume":"10","author":"Song","year":"2011","journal-title":"J Proteome Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1128\/JVI.01615-07","article-title":"Induction of heterosubtypic immunity to influenza virus by intranasal immunization","volume":"82","author":"Quan","year":"2008","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.virol.2010.05.034","article-title":"Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles","volume":"405","author":"Song","year":"2010","journal-title":"Virology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/imm.12310","article-title":"Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination","volume":"143","author":"Lee","year":"2014","journal-title":"Immunology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7764","DOI":"10.1128\/JVI.00748-14","article-title":"Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination","volume":"88","author":"Eunju","year":"2014","journal-title":"J Virol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4049\/jimmunol.1600173","article-title":"Roles of aluminum hydroxide and monophosphoryl lipid A adjuvants in overcoming CD4+ T cell deficiency to induce isotype-switched IgG antibody responses and protection by T-dependent influenza vaccine","volume":"198","author":"Ko","year":"2017","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1084\/jem.20021745","article-title":"An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions","volume":"198","author":"Sangster","year":"2003","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.antiviral.2013.06.010","article-title":"Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection","volume":"99","author":"Kim","year":"2013","journal-title":"Antiviral Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1016\/j.vaccine.2014.08.030","article-title":"Influenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunity","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1073\/pnas.1012199108","article-title":"Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus","volume":"108","author":"Song","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e14538","DOI":"10.1371\/journal.pone.0014538","article-title":"Influenza virus-like particles containing M2 induce broadly cross protective immunity","volume":"6","author":"Song","year":"2011","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1099\/0022-1317-80-10-2559","article-title":"Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein","volume":"80","author":"Chen","year":"1999","journal-title":"J Gen Virol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1128\/CVI.05206-11","article-title":"Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza","volume":"18","author":"Hossain","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.virol.2006.12.014","article-title":"Human immunodeficiency virus-like particles activate multiple types of immune cells","volume":"362","author":"Sailaja","year":"2007","journal-title":"Virology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/vim.2013.0013","article-title":"Mucosal adjuvants for influenza virus-like particle vaccine","volume":"26","author":"Quan","year":"2013","journal-title":"Viral Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"24402","DOI":"10.1038\/srep24402","article-title":"Long-lasting cross-protection against influenza A by neuraminidase and M2e-based immunization strategies","volume":"6","author":"Schotsaert","year":"2016","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/mi.2012.69","article-title":"Natural and long-lasting cellular immune responses against influenza in the M2e-immune host","volume":"6","author":"Schotsaert","year":"2013","journal-title":"Mucosal Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.smim.2004.02.004","article-title":"CD4 T cell responses to influenza infection","volume":"16","author":"Brown","year":"2004","journal-title":"Semin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01730\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T20:29:37Z","timestamp":1603484977000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01730\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2017.01730"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01730","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]},"article-number":"1730"}}